Radiaction Medical Appoints Christopher Barys as New US President and Chief Commercial Officer
Retrieved on:
Tuesday, October 24, 2023
Radiaction Medical , LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today announced that it has appointed industry veteran Christopher Barys to serve as its US President and Chief Commercial Officer.
Key Points:
- Radiaction Medical , LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today announced that it has appointed industry veteran Christopher Barys to serve as its US President and Chief Commercial Officer.
- View the full release here: https://www.businesswire.com/news/home/20231024917670/en/
Christopher Barys, US President and Chief Commercial Officer, Radiaction Medical, Ltd. (Photo: Business Wire)
“In the midst of a rapidly changing healthcare environment, protection for interventional staff has remained stagnant, to the detriment of those healthcare workers who are in the direct line of harm from scatter radiation,” Barys said. - “Innovative, clinically supported solutions are needed now more than ever, and Radiaction is answering the call.
- Jonathan Yifat, Radiaction CEO, said, “When we met Chris, I knew he had the right experience and vision to steer Radiaction through our next stage of growth.